Down 38.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Cyclerion Therapeutics, Inc. (CYCN)

Published on 15 Dec 2021 on Entrpreneur

Cyclerion Therapeutics, Inc. (CYCN) has been on a downward spiral lately with significant selling...

Read the rest of the article

Start tracking your investments with Statfolio

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip ou...

Insider Monkey via Yahoo Finance 24 Mar 2024

Insiders who bought US$1.95m worth of Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) stock at an av...

Simply Wall St. via Yahoo Finance 29 Nov 2023

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYC...

American City Business Journals 5 Aug 2023

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (form...

Benzinga via Yahoo Finance 12 May 2023

GreenLight Biosciences Holdings Inc. is laying off a quarter of its staff eight months after it w...

American City Business Journals 27 Oct 2022

Cyclerion Therapeutics Inc. is culling its workforce as it narrows its focus to mitochondrial...

American City Business Journals 7 Oct 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15%

Investing.com 6 Oct 2022

Cyclerion Therapeutics Inc (NASDAQ: CYCN) is reprioritizing development programs and focusing res...

Benzinga via Yahoo Finance 6 Oct 2022

Investing.com 6 Oct 2022

Cyclerion Therapeutics, Inc. (CYCN) came out with a quarterly loss of $0.31 per share versus the ...

Zacks via Yahoo Finance 10 Aug 2022